What Is Evotec SE (EVO) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, our multi-model framework produces a cautiously optimistic read on Evotec SE at $2.01. With an estimated intrinsic value of $2.85 and 7 of 10 models pointing higher, the average implied return is +41.6%. The most optimistic model, First Chicago, places fair value at $5.88 (+192.4%), while Bayesian DCF — the most conservative — estimates $0.22 (-89.1%). This +281.6% gap reflects genuine analytical uncertainty about Evotec SE's intrinsic worth.
What Do the Models Say About EVO?
10 of 13 models are currently active for EVO. Of these, 8 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates EVO's intrinsic value at $0.22, implying -89.1% downside from the current price. See which stocks rank higher →
How Does EVO Rank in Pharmaceutical Preparations?
Among 431 Pharmaceutical Preparations stocks, EVO ranks #83 by Quality of Company score. CirclFi's QOC score of 6.5/10 evaluates 32 fundamental signals. A score of 6.5 indicates above-average quality.
See all Most Undervalued Pharmaceutical Preparations Stocks →
Evotec SE's positioning within the Pharmaceutical Preparations segment means that R&D productivity ratio plays an outsized role in fundamental analysis. The sector's unique characteristics — including regulatory pathway clarity — shape both the opportunity set and risk profile.
Is EVO a Value Trap?
CirclFi's Value Trap algorithm assigns EVO a score of 15/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
10 of 13 models are active for Evotec SE. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Deep Alpha Valuation Engine, Evotec SE scores 6.5 out of 10 on our 32-signal quality assessment, a solid rating that maintains reasonable quality metrics with some areas for improvement. The QOC score synthesizes profitability margins, revenue growth reliability, debt management, and capital allocation into a single metric designed to separate durable businesses from statistically cheap ones.
The gap between the most bullish and bearish model spans +281.6% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every EVO valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across EVO's 10 active models, average confidence is 20%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad